Recursion Pharmaceuticals, Inc. logo RXRX - Recursion Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 4
HOLD 6
SELL 0
STRONG
SELL
0
| PRICE TARGET: $5.30 DETAILS
HIGH: $5.30
LOW: $5.30
MEDIAN: $5.30
CONSENSUS: $5.30
UPSIDE: 67.72%

Institutional Holders (13F)

GURU SHARES VALUE WEIGHT % SHARES CHG ACTION
Cooperman 37,914 $139,144 0.0% -8,094 DECREASED
Dalio 37,667 $138,238 0.0% +37,667 NEW
Wood 0 $0 -- -46,300 SOLD

Insider Trading

BUYS (12M) 0
SELLS (12M) 37
BUY VALUE $0
SELL VALUE $9.4M
DATE INSIDER TITLE TYPE SHARES PRICE VALUE
2026-09-08 Khan Najat director, officer: CEO and President SELL 22,408 $3.52 $79K
2026-09-01 Borgeson Blake director SELL 30,000 $3.34 $100K
2026-08-17 Khan Najat director, officer: CEO and President F-InKind 80,498 $3.16 $254K
2026-08-17 Hallett David officer: Chief Scientific Officer F-InKind 26,657 $3.16 $84K
2026-08-17 Taylor Ben R officer: Chief Financial Officer F-InKind 25,018 $3.16 $79K
2026-08-04 Borgeson Blake director SELL 30,000 $3.25 $98K
2026-07-07 Borgeson Blake director SELL 40,000 $3.96 $158K
2026-07-01 Dar Zavain director A-Award 5,109 -- --
2026-07-01 Li Dean Y director A-Award 3,747 -- --
2026-06-17 Borgeson Blake director A-Award 88,424 -- --
2026-06-17 HERSHBERG ROBERT director A-Award 88,424 -- --
2026-06-17 Michor Franziska director A-Award 88,424 -- --
2026-06-17 Sun Elaine D director A-Award 88,424 -- --
2026-06-17 Dar Zavain director A-Award 88,424 -- --
2026-06-17 Li Dean Y director A-Award 88,424 -- --
2026-06-17 Bumpus Namandje director A-Award 88,424 -- --
2026-06-18 Bumpus Namandje director SELL 3,963 $3.18 $13K
2026-06-15 Taylor Ben R officer: Chief Financial Officer F-InKind 5,396 $3.15 $17K
2026-06-05 Khan Najat director, officer: CEO and President SELL 23,588 $3.58 $84K
2026-06-05 Gibson Christopher director C-Conversion 40,000 -- --
2026-06-05 Gibson Christopher director SELL 40,000 $3.62 $145K
2026-06-02 Borgeson Blake director SELL 30,000 $3.68 $110K
2026-06-03 Bumpus Namandje director SELL 4,386 $3.54 $16K
2026-05-22 Gibson Christopher director C-Conversion 40,000 -- --
2026-05-22 Gibson Christopher director SELL 40,000 $3.08 $123K

Congressional Trading

No congressional trading data for RXRX.